Anti-Avian Influenza Matrix Protein I 抗体 (ab25918)
Key features and details
- Rabbit polyclonal to Avian Influenza Matrix Protein I
- Suitable for: WB, ICC/IF
- Reacts with: Influenza A
- Isotype: IgG
製品の概要
-
製品名
Anti-Avian Influenza Matrix Protein I antibody
Avian Influenza Matrix Protein I 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to Avian Influenza Matrix Protein I -
由来種
Rabbit -
アプリケーション
適用あり: WB, ICC/IFmore details -
種交差性
交差種: Influenza A -
免疫原
Synthetic peptide:
SGPLKAEIAQRLEDVFAGKN
, corresponding to amino acids 9-28 of Chicken Avian Influenza Matrix Protein 1. -
ポジティブ・コントロール
- Recombinant fusion protein.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.4
Preservative: 0.05% Sodium azide
Constituent: 0.05% BSA -
Concentration information loading...
-
精製度
Protein G purified -
特記事項(精製)
This antibody was purified by chromatography. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab25918の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 27 kDa.
|
|
ICC/IF |
1/10.
|
特記事項 |
---|
WB
Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 27 kDa. |
ICC/IF
1/10. |
ターゲット情報
-
関連性
An H6N1 influenza virus was isolated from a green-winged teal during the H5N1 outbreak in Hong Kong Special Administrative Region (SAR) in 1997. This virus possesses similar genes encoding internal proteins as in the human H5N1 and H9N2 influenza viruses. In 1999, influenza viruses from quail infected two humans in Hong Kong, suggesting the potential for avian influenza viruses to cross the species barrier and infect humans without prior reassortment in an intermediate host, such as the pig. The common features shared by H5N1 and H9N2 influenza viruses isolated from humans are the genes encoding the proteins of the replicating complex, the matrix protein (M) gene, the nonstructural protein (NS) gene, N1 neuraminidase (NA), This virus essentially represents the reemergence of the H5N1 influenza viruses with a different hemagglutinin (HA). -
参照データベース
- SwissProt: Q809Z8 Influenza A
-
別名
- M antibody
- M1 antibody
- M1 matrix protein 1 antibody
- Matrix protein 1 antibody
画像
-
All lanes : Anti-Avian Influenza Matrix Protein I antibody (ab25918) at 0.5 µg/ml (Western blot analysis of Avian Flu Matrix Protein 1.)
Lane 1 : Recombinant fusion protein containing amino acids 9-28 (A). at 0.1 µg
Lane 2 : Fusion partner without these amino acids (B).
Predicted band size: 27 kDa -
Immunofluoroscence staining of influenza infected MDCK cells using ab25918 at 1/10 dilution. Image courtesy of Catherine Thompson, The University of Reading.
プロトコール
データシートおよび資料
-
Datasheet download
参考文献 (3)
ab25918 は 3 報の論文で使用されています。
- Mizuno K et al. Nicotinic acetylcholine receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via calmodulin kinase IV activation. J Neurosci Res 93:660-5 (2015). Flow Cyt ; Human . PubMed: 25430056
- Lin SC et al. Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles. PLoS One 7:e39075 (2012). WB . PubMed: 22720032
- Pan YS et al. Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol 2010:506363 (2010). WB . PubMed: 21197092